That seems to sum up medical advancement i guess. It works both ways as the FDA or whoever make it so expensive to get a drug to market, though at the same time we absolutely need to be sure of safety. Medical costs are just spiralling though. Pyc could quite possibly have developed imyc as a great cancer treatment but it got dropped pretty much for financial reasons it seems. Sad world. But at least pyc is rising and apparently holding for the first time in a decade.
Ann: Successful Competitive Drug Evaluation in Animals, page-18
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.8¢ |
Change
-0.003(1.25%) |
Mkt cap ! $898.2M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 19.3¢ | $292.3K | 1.475M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 212803 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 289194 | 6 |
View Market Depth
| Last trade - 11.25am 17/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |